Cargando…

Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders

The gut–brain axis is a bidirectional communication network connecting the gastrointestinal tract and central nervous system. The axis keeps track of gastrointestinal activities and integrates them to connect gut health to higher cognitive parts of the brain. Disruption in this connection may facili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandpal, Meenakshi, Indari, Omkar, Baral, Budhadev, Jakhmola, Shweta, Tiwari, Deeksha, Bhandari, Vasundhra, Pandey, Rajan Kumar, Bala, Kiran, Sonawane, Avinash, Jha, Hem Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692419/ https://www.ncbi.nlm.nih.gov/pubmed/36355147 http://dx.doi.org/10.3390/metabo12111064

Ejemplares similares

Comorbidity Assessment Is Essential During COVID-19 Treatment
por: Jakhmola, Shweta, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
por: Indari, Omkar, et al.
Publicado: (2021)

Recent updates on COVID-19: A holistic review
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin
por: Kashyap, Dharmendra, et al.
Publicado: (2021)

Mutational analysis of structural proteins of SARS-CoV-2
por: Jakhmola, Shweta, et al.
Publicado: (2021)

Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations
por: Indari, Omkar, et al.
Publicado: (2021)

Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study
por: Indari, Omkar, et al.
Publicado: (2022)

Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
por: Anand, Uttpal, et al.
Publicado: (2021)

A review of the presence of SARS-CoV-2 RNA in wastewater and airborne particulates and its use for virus spreading surveillance
por: Anand, Uttpal, et al.
Publicado: (2021)

Temporal In Vitro Raman Spectroscopy for Monitoring Replication Kinetics of Epstein–Barr Virus Infection in Glial Cells
por: Tiwari, Deeksha, et al.
Publicado: (2020)

The interrelation of COVID-19 and neurological modalities
por: Jakhmola, Shweta, et al.
Publicado: (2021)

Outer Membrane Vesicles: An Emerging Vaccine Platform
por: Kashyap, Dharmendra, et al.
Publicado: (2022)

Herpesviral interplay with peroxisome: An underexplored viral niche
por: Indari, Omkar, et al.
Publicado: (2023)

Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach
por: Sonkar, Charu, et al.
Publicado: (2020)

Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
por: Chattopadhyay, Indranil, et al.
Publicado: (2022)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Gut Dysbiosis and Kidney Diseases
por: Cao, Chujin, et al.
Publicado: (2022)

COVID-19 and gut dysbiosis, understanding the role of probiotic supplements in reversing gut dysbiosis and immunity
por: Aldhafiri, Fahad K.
Publicado: (2022)

Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders
por: Singh, Rajan, et al.
Publicado: (2021)

Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology
por: Wei, Lai, et al.
Publicado: (2021)

Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
por: Singh, Samradhi, et al.
Publicado: (2023)

Gut-Thyroid axis: How gut microbial dysbiosis associated with euthyroid thyroid cancer
por: Ishaq, Hafiz Muhammad, et al.
Publicado: (2022)

Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012)

Gut Dysbiosis in Patients with Anorexia Nervosa
por: Morita, Chihiro, et al.
Publicado: (2015)

Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019)

Hyperoxia provokes gut dysbiosis in rats
por: Xing, Zhouxiong, et al.
Publicado: (2020)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Gut dysbiosis and mortality in hemodialysis patients
por: Lin, Ting-Yun, et al.
Publicado: (2021)

Epigenetic Regulation of Gut Microbial Dysbiosis
por: Srivastava, Shivani, et al.
Publicado: (2021)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
por: Anjana,, et al.
Publicado: (2022)

Potential entry receptors for human γ-herpesvirus into epithelial cells: A plausible therapeutic target for viral infections
por: Rani, Annu, et al.
Publicado: (2021)

The prophylactic effects of BIFICO on the antibiotic-induced gut dysbiosis and gut microbiota
por: Wu, Jiannong, et al.
Publicado: (2020)

Retraction: Human gut microbiota: dysbiosis and manipulation
Publicado: (2013)

Gut microbiota dysbiosis contributes to the development of hypertension
por: Li, Jing, et al.
Publicado: (2017)

Gut-lung axis and dysbiosis in COVID-19
por: AKTAS, Busra, et al.
Publicado: (2020)

Current Perspectives on Gut Microbiome Dysbiosis and Depression
por: Capuco, Alexander, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vuka1bdsbq2qhgkq3ghimv0a6b